Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction

Medical Science Monitor

Volumn 15, Issue 9, 2009, Pages

  Knapp, Małgorzata ^a   Baranowski, Marcin ^a   Czarnowski, Dariusz ^a   Lisowska, Anna ^a   Zabielski, Piotr ^a   Górski, Jan ^a   Musiał, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramide; Human; Myocardial infarction; Plasma; Sphingolipids; Sphingosine 1 phosphate

Indexed keywords

ACETYLSALICYLIC ACID; CERAMIDE; CLOPIDOGREL; HEPARIN; SPHINGANINE; SPHINGANINE 1 PHOSPHATE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL ADMISSION; HUMAN; MALE;

AGED; ANIMALS; CERAMIDES; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECEPTORS, LYSOSPHINGOLIPID; REPERFUSION INJURY; SPHINGOSINE; THROMBOLYTIC THERAPY;

EID: 70349908135     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Means CK, Xiao CY, Li Z et al: Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 2007; 292: H2944-51
2. Keul P, Sattler K, Levkau B: HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev, 2007; 12: 301-306 (Pubitemid 350176703)
3. Merril AH, Schmelz EM, Dillehay DL et al: Sphingolipids - the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol, 1997; 142: 208-225
4. Meyer zu Heringdorf D, Jakobs KH: Lysophospholipid receptors: Signaling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys. Acta, 2007; 1768: 923-940
5. Tao R, Zhang J, Vessey DA et al: Deletion of the Sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res, 2007; 74: 56-63 (Pubitemid 46366955)
6. Jin ZQ, Goetzl EJ, Karliner JS: Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation, 2004; 110: 1980-1989
7. Duan HF, Wang H, Yi J et al: Adenovirus gene transfer of sphingosine kinase 1 protects against ischemia/reperfusion injury and attenuates its postischemic failure. Humane Gene Therapy, 2007; 18: 1119-1128 (Pubitemid 350114687)
8. Jin ZQ, Zhang J, Huang Y et al: A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res, 2007; 76: 41-50 (Pubitemid 47362044)
9. Vessey DA, Kelley M, Li L et al: Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit, 2006; 12(10): BR318-24 (Pubitemid 44556077)
10. Jin ZQ, Zhou HZ, Zhu P et al: Cardioprotection mediated by sphingosine- 1-phosphate and ganglioside GM-1 in wild-type and PKCe knockout mouse hearts. Am J Physiol Heart Circ Physiol, 2002; 282: H1970-77 (Pubitemid 34663002)
11. Zhang JQ, Honbo N, Goetzl EJ et al: Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol, 2007; 293: H3150-58 (Pubitemid 350106541)
12. Ito K, Anada Y, Tani M et al: Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun, 2007; 357: 212-217 (Pubitemid 46574517)
13. Hänel P, Andréani P, Gräler MH: Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J, 2007; 21: 1202-1209
14. Yatomi Y, Igarashi L, Yang L et al: Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem, 1997; 121: 969-973 (Pubitemid 27236918)
15. Thygesen K, Alpert JS, White HD (on behalf of the Joint ESC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction): Universal definition of myocardial infarction. Eur Heart J, 2007; 28: 2525-2538
16. Min JK, Yoo HS, Lee EY et al: Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivitization after dephosphorylation with alkaline phosphatase. Anal Biochem, 2002; 303: 167-175
17. Bose R, Chen P, Loconti A et al: Ceramide generation by the Reaper protein is not blocked by the caspase inhibitor, p35. J Biol Chem 1998; 273: 28852-28859 (Pubitemid 28507576)
18. Gómez-Muñoz A: Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim Biophys Acta, 2006; 1758: 2049-2056 (Pubitemid 44911057)
19. Mari M, Fernández-Checa JC: Sphingolipid signaling and liver diseases. Liver Internat, 2007; 27: 440-450
20. Beresewicz A, Dobrzyn A, Gorski J: Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning. J Physiol Pharmacol, 2002; 53: 371-382
21. Venkataraman K, Thangada S, Michaud J et al: Extracellular export of sphingosine kinase 1a contributes to the vascular S1P gradient. Biochem J, 2006; 397: 461-471 (Pubitemid 44187504)
22. Spiegel S, Milstien S: Functions of a new family of sphingosine-1- phosphate receptors. Biochim Biophys Acta, 2000; 1484: 107-116 (Pubitemid 30175961)